Nicolaus Westerkamp has joined the pharma group MSD as director International Legal & Compliance. Nicolaus is, as he defined himself, a seasoned in-house counsel and business enabler with over 13 years of experience negotiating complex technology
Tags :dx2
In a strategic move to diversify its product portfolio, Swiss company Martec Handels has successfully acquired the renowned Swiss brand, Renuwell. Specializing in the development, distribution, and marketing of non-food consumer goods within the specialty
Christian Haitz is the new head of legal and compliance at Gryphon Invest and NOVO Swiss, part of ACE SWISS Holding. With an abundance of in-house experience, he has previously provided legal services to several
Lenz & Staehelin presents its new corporate identity. At the centre is the new logo, which for the first time uses the tried and tested abbreviation L&S and graphically expresses how Lenz &
Wenger Vieli advised Oaks, an embedded fintech startup, on all Swiss legal matters. The round was led by Atlanics Labs with participation of a set of tier 1 international angels. The funding will allow Oaks to
Walder Wyss acted as legal counsel to Ionisos SAS on its recent acquisition of an E-beam sterilization and cross-linking facility from Studer Cables. Studer Cables, a prominent technology company specializing in high-performance cables for various
The Federal Supreme Court confirms far-reaching injunctions granted in favor of the German science and technology company Merck by the Commercial Court of the Canton of Zurich against Merck’s US competitor MSD. Based in
Bär & Karrer acted as legal advisor to terreActive, a company based in Aarau, in the recent majority stake acquisition by Swiss Post. This strategic move is aimed at enhancing Swiss Post’s expertise
The Young International Arbitration Group (‘YIAG’), an association supported by the London Court of International Arbitration (‘LCIA’) and dedicated to practitioners, students, and young members of the arbitration community, has recently announced the appointment of
Schellenberg Wittmer acted as Swiss counsel to SPRIM Global Investments (SGI), a leading health sciences venture capital firm, in its capital commitment of USD 4.5 million in favor of Spexis, a clinical-stage and biopharmaceutical company listed
